LGALS2 suppresses the progression of papillary thyroid carcinoma by regulating the PI3K/AKT pathway

BACKGROUND: The galectin 2 (LGALS2) protein has been shown to be associated with the pathogenic progression of a range of cancer types, yet its role in papillary thyroid carcinoma (PTC) remains poorly defined. Accordingly, the present study was conducted to address this gap in the literature. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Debin, Guo, Liangyun, Zhang, Shuyong, Hou, Qian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547712/
https://www.ncbi.nlm.nih.gov/pubmed/36221286
http://dx.doi.org/10.21037/gs-22-452

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547712/
https://www.ncbi.nlm.nih.gov/pubmed/36221286
http://dx.doi.org/10.21037/gs-22-452

Ejemplares similares